An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)



Status:Recruiting
Conditions:Orthopedic, Hematology
Therapuetic Areas:Hematology, Orthopedics / Podiatry
Healthy:No
Age Range:1 - 74
Updated:4/5/2019
Start Date:February 21, 2018
End Date:January 2020
Contact:Clinical Trial Disclosure & Transparency
Email:ClinicalTrialDisclosure@JazzPharma.com
Phone:215-832-3750

Use our guide to learn which trials are right for you!

A Phase 2, Prospective, Randomized, Open-Label Study on the Efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the Prevention of Acute Graft-versus-Host-Disease in Adult and Pediatric Patients After Allogeneic Hematopietic Stem Cell Transplant

This is a study comparing the defibrotide prophylaxis arm vs standard of care arm for the
prevention of aGvHD.


Inclusion Criteria:

1. Patient must be ≥1 year and <75 years of age at screening and undergoing allogeneic
HSCT.

2. Patient must be diagnosed with acute leukemia in morphologic complete remission (CR1
or CR2) or with MDS with no circulating blasts and with less than 5% blasts in the
bone marrow

3. Patient must have planned to receive either a myeloablative or reduced-intensity
conditioning regimen and have an unrelated donor who is HLA matched or single-allele
mismatched

4. Patient must receive the following medical regimen as part of standard of care
immunoprophylaxis for GvHD in either study arm at doses and regimen determined by
local institutional guidelines, physician preference, and patient need:

MTX or MMF + calcineurin inhibitor (CSA or TAC) +/- ATG (ATG use is limited to 30% of
patients).

5. Graft must be a CD3+ T-cell replete PBSC graft or non-manipulated BM graft.

6. Adult patients must be able to understand and sign a written informed consent. For
pediatric patients, the parent/legal guardian or representative must be able to
understand and sign a written informed consent. Assent, when appropriate, will be
obtained according to institutional guidelines.

Exclusion Criteria:

1. Patient has had a prior autologous or allogeneic HSCT.

2. Patient is using or plans to use an investigational agent for the prevention of GvHD.

3. Patient is receiving or plans to receive other investigational therapy and/or is
enrolled or plans to enroll in a separate clinical study.

4. Patient, in the opinion of the investigator, may not be able to comply with the safety
monitoring requirements of the study.

5. Patient has a psychiatric illness that would prevent the patient or legal guardian or
representative from giving informed consent and/or assent.

6. Patient has a serious active disease or co-morbid medical condition, as judged by the
investigator, which would interfere with the conduct of this study.

7. Patient is pregnant or lactating and does not agree to stop breastfeeding.

8. Any other condition that would cause a risk to the patient if he/she participated in
the trial.

9. Patient has a known history of hypersensitivity to defibrotide or any of the
excipients.
We found this trial at
10
sites
505 Parnassus Ave
San Francisco, California 94143
(415) 476-1000
University of California, San Francisco Medical Center UCSF Medical Center is recognized throughout the world...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
(919) 962-2211
University of North Carolina at Chapel Hill Carolina’s vibrant people and programs attest to the...
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
1364 Clifton Rd NE
Atlanta, Georgia 30322
(404) 712-2000
Emory University Hospital As the largest health care system in Georgia and the only health...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Brussels,
Click here to add this to my saved trials
Charleston, South Carolina 29425
?
mi
from
Charleston, SC
Click here to add this to my saved trials
500 University Dr
Hershey, Pennsylvania 17033
(717) 531-6955
Penn State Milton S. Hershey Medical Center Penn State Milton S. Hershey Medical Center, Penn...
?
mi
from
Hershey, PA
Click here to add this to my saved trials
Morgantown, West Virginia
?
mi
from
Morgantown, WV
Click here to add this to my saved trials
Emile St
Omaha, Nebraska 68198
(402) 559-4000
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Orlando, Florida 32804
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Westwood, Kansas 66205
?
mi
from
Westwood, KS
Click here to add this to my saved trials